Condition: Atypical Endometrial Hyperplasia · Endometrial Carcinoma Stage I · Sponsor: Peking University People's Hospital
To explore the treatment efficacy of medroxyprogesterone acetate plus atorvastatin in patients with atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EEC) for conservative treatment.
This description comes directly from the study's public registry record.
WANG JIANLIU, PhD/MD · +861088324383 · wangjianliu1203@163.com
HE YIJIAO, PhD · +8618301512017 · heyijiao2017@pku.edu.cn
Always discuss trial participation with your own doctor first.
| Wang Jianliu | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05675787